Research from the Francis Crick Institute suggests that frequent blood donation may have potential health benefits for donors. A study led by Hector Huerga Encabo analyzed genetic data from blood samples of 217 men aged 60 to 72 who had donated blood more than 100 times. These samples were compared with those from 212 men of a similar age who had donated fewer than 10 times. The findings indicated that frequent donors were more likely to have blood cells with specific beneficial mutations in a gene known as DNMT3A.
The researchers conducted laboratory experiments using genetically engineered blood stem cells, simulating the effects of blood donation by introducing EPO, a hormone the body produces after blood loss. They found that cells with the DNMT3A mutations grew significantly faster—by approximately 50%—when EPO was present, compared to unmodified cells. This growth advantage suggests that blood donation may create an environment that favors the proliferation of healthier blood cells.
Furthermore, when mixed with cells that carry mutations associated with an increased risk of leukemia, the mutated cells from frequent donors outperformed the others in growth and red blood cell production. This raises the possibility that these mutations could potentially suppress the development of cancerous cells.
Despite these promising results, experts emphasize the need for further research to validate these findings across larger and more diverse populations. Marc Mansour from University College London cautions that laboratory results may not fully represent biological responses in the body, and that individuals without the DNMT3A mutation may not experience these benefits. Overall, while the study opens new avenues for understanding the relationship between blood donation and health, more comprehensive research is necessary to draw definitive conclusions.